Article info

Download PDFPDF

Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR

Authors

  1. Correspondence to Dr Theresa L Walunas; t-walunas{at}northwestern.edu; Dr William J Murphy; wmjmurphy{at}ucdavis.edu; Dr Alexandra-Chloé Villani; avillani{at}mgh.harvard.edu
View Full Text

Citation

Bayless NL, Bluestone JA, Bucktrout S, et al
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR

Publication history

  • Accepted July 14, 2021
  • First published September 3, 2021.
Online issue publication 
September 03, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.